about
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesisSimple model for testing drugs against nonreplicating Mycobacterium tuberculosisDelayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.Rapid cytolysis of Mycobacterium tuberculosis by faropenem, an orally bioavailable β-lactam antibiotic.An Amidase_3 domain-containing N-acetylmuramyl-L-alanine amidase is required for mycobacterial cell division.Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.EspI regulates the ESX-1 secretion system in response to ATP levels in Mycobacterium tuberculosis.The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivoSimple and rapid method to determine antimycobacterial potency of compounds by using autoluminescent Mycobacterium tuberculosisEspD is critical for the virulence-mediating ESX-1 secretion system in Mycobacterium tuberculosis.Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis InfectionStreptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis.Microbial phenotypic heterogeneity and antibiotic tolerance.Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor.Phenotypic profiling of Mycobacterium tuberculosis EspA point mutants reveals that blockage of ESAT-6 and CFP-10 secretion in vitro does not always correlate with attenuation of virulence.Division site selection linked to inherited cell surface wave troughs in mycobacteria.4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.Bioluminescence for assessing drug potency against nonreplicating Mycobacterium tuberculosis.Assessing the essentiality of the decaprenyl-phospho-d-arabinofuranose pathway in Mycobacterium tuberculosis using conditional mutants.Mycobacterium tuberculosis EspB binds phospholipids and mediates EsxA-independent virulence.Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria.Stress and host immunity amplify Mycobacterium tuberculosis phenotypic heterogeneity and induce nongrowing metabolically active forms.Development of a repressible mycobacterial promoter system based on two transcriptional repressors.Disruption of mptpB impairs the ability of Mycobacterium tuberculosis to survive in guinea pigs.Single-cell dynamics of the chromosome replication and cell division cycles in mycobacteria.Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs.Increased expression of Mycobacterium tuberculosis 19 kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype.Stressed mycobacteria use the chaperone ClpB to sequester irreversibly oxidized proteins asymmetrically within and between cells.Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase.Dielectrophoresis-based purification of antibiotic-treated bacterial subpopulations.Single-cell analysis of mycobacteria using microfluidics and time-lapse microscopy.Erratum for Boldrin et al., The Phosphatidyl-myo-Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo.Recombinant BCG approach for development of vaccines: cloning and expression of immunodominant antigens of M. tuberculosisImmunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosisSkewing of the Th1/Th2 responses in mice due to variation in the level of expression of an antigen in a recombinant BCG systemModulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-GuérinNanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis
P50
Q27672587-3783950B-7E62-4EEF-83A0-4B6A5FAE9030Q27696214-33170889-0D16-48A7-8E67-94C9C9FEEB6DQ28486345-340945BE-F2E0-4728-B237-DAC737309E4FQ30496706-9C6CCE4C-2410-4228-9D90-3048D9C0D2EDQ30573771-15A3A5FF-000D-4060-8C6D-0E2527BD36B5Q30620897-7FA8997E-0925-4130-8386-CC82971B42C1Q30850531-1D22A65D-2E30-45F8-B29E-CF20A2A0DCCCQ33389187-C9FC5C82-0475-4220-8213-D44D9FBDCB71Q33798173-954CA9F7-52E2-4B51-85EE-D78E4FF4E92BQ34115756-8DC85CCE-0A1B-4042-ACD2-B2FE45DFB833Q34297745-2E97F723-7592-4458-B7B9-68BAD6F61BAEQ35210821-68EADD66-8552-4D4B-B1CA-E002515BE1C7Q35739146-034710C8-9AAA-445C-B825-DE723ACDDA9EQ35860128-DA7C6CEA-F31A-473B-9F64-5B925341B76CQ36364079-55EAE9B4-80B6-4373-BD95-9251741AF21EQ36704124-E631C535-0770-461A-B34A-33E9C3A2F1CBQ37034701-8E1AE566-D28F-4499-B9B6-379F04C4B47FQ37469773-5603F5B3-B772-4F97-8F9C-3C903469A9B5Q38666658-78A06AB2-C83B-4384-AD06-7D206782EC76Q38990739-950CBC45-2B24-4DF7-B931-B0CD3EC542BEQ39015804-FAB3E871-0AC5-4F17-BD16-14198BDBAE58Q39024963-80110097-7F5A-4728-8047-ECF9D27EC412Q39123504-C0666E48-E1F8-407E-B1AE-F4B96FCA84CAQ39345865-E0A6856B-39A4-4459-8EC6-A995F7A27603Q41579776-F1E1FBF4-E74B-4625-9B18-A41665AD5A20Q41902289-0B5288AF-0799-488B-B287-068BCFDFBD24Q44655558-2DA7CE65-35EA-41D6-90E1-55A8A7EB8F1DQ44940038-DD9B0DD3-D3D1-4D28-868F-5D2F101C3744Q46806707-50F5C27C-50AD-46A9-A59F-39A0A39AF40FQ46939320-2FDCF8CC-7537-4668-A3C2-446C9B56A38FQ47118931-0A0C763D-DE5E-47EB-AB17-EBF769DAC0E5Q49049841-8CB535A8-E934-4E54-A969-EB643421DB50Q51517297-CF559300-FBDF-4E73-BB5B-54893AA59A54Q53021148-712B5C1F-3A2D-4485-B944-D3DEE892F839Q55478266-F3C6F637-D9FF-43BA-848E-038001BBFCDDQ73084495-807CD56A-F985-4881-BB4C-0DB71E58384AQ73774133-0E5157DE-C163-410A-A69A-5600AB7911B6Q73863578-E814E74A-E3F2-4515-A31A-B45367C9F752Q79079857-E8AAF604-1F86-4E56-A7ED-80CC7BEAEDC2Q84592120-B2FFC80D-B806-45AC-8552-D2122992B99D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Neeraj Dhar
@ast
Neeraj Dhar
@en
Neeraj Dhar
@es
Neeraj Dhar
@nl
type
label
Neeraj Dhar
@ast
Neeraj Dhar
@en
Neeraj Dhar
@es
Neeraj Dhar
@nl
prefLabel
Neeraj Dhar
@ast
Neeraj Dhar
@en
Neeraj Dhar
@es
Neeraj Dhar
@nl
P1053
K-8171-2013
P106
P1153
35483448400
P31
P4012
P496
0000-0002-5887-8137